Essilor strengthens its operations in France with the acquisition of
Interactif Visuel Système
CHARENTON-LE-PONT, France -- January 11, 2013
Essilor (Paris:EI) has announced the acquisition of 68.3% of the capital of
Interactif Visuel Système (IVS), a global leader in technological sales
support solutions for opticians. IVS designs, develops and sells a wide range
of sales support and ophthalmic measurement solutions, under the Activisu^®
brand. They include the Visioffice^® measuring column, designed jointly with
Essilor, that allows eyecare professionals to dispense Varilux^® premium
lenses, including the latest Varilux^® S 4D. Created in Paris, France over 15
years ago, IVS has more than 80 employees and generates revenue of around €20
IVS’s solutions are present across five continents and represent some 30,000
software licenses in over 17,000 points of sale. At the forefront of
technological innovation, these solutions are protected by patents on
ophthalmic measurement-taking, combining live measurement by video stream,
three-dimensional modeling of the eye and simulation of visual behavior
strategies. IVS is also present in the digital media market, through its
In addition to having a strong culture of innovation, fostered by the creative
drive of its founders Benoist Monot and Pascal Thomet, IVS is a good strategic
fit with Essilor. The partnership allows Essilor to respond to the growing
demand for lens personalization, to forge closer ties with eyecare
professionals and to enhance its range of services for them. IVS’s
technologies will also enable Essilor to accelerate the deployment of its
technological innovations and its next generation lenses. In the future, the
combined expertise of IVS and Essilor will create a richer and more
competitive range of products and services for all eyecare professionals.
Speaking about this partnership, Hubert Sagnières, Chairman and Chief
Executive Officer, said, “IVS technologies, combined with the strengths of our
Instrument Division, will allow us to distribute high performance measurement
tools more rapidly across all market segments throughout the world, in order
to meet rising demand for personalized lenses. This partnership also
illustrates Essilor’s ongoing commitment to meeting optician clients’ needs
for differentiating high-end solutions, as well as to making innovations more
With this transaction, Essilor is continuing to expand in its domestic market,
while maintaining its commitment to partnering the global deployment of
innovative small and medium-sized companies in its sector.
The world’s leading ophthalmic optics company, Essilor designs, manufactures
and markets a wide range of lenses to improve and protect eyesight. Its
corporate mission is to enable everyone around the world to access lenses that
meet his or her unique vision requirements. To support this mission, the
Company allocates around €150 million to research and development every year,
in a commitment to continuously bring new, more effective products to market.
Essilor’s flagship brands are Varilux^®, Crizal^®, Definity^®, Xperio^®,
Optifog^TM and Foster Grant^®. It also develops and markets equipment,
instruments and services for eyecare professionals.
Essilor reported consolidated revenue of €4.2 billion in 2011 and employs
around 48,700 people in some 100 countries. It operates 19 plants, a total of
390 prescription laboratories and edging facilities, as well as several
research and development centers around the world.
For more information, please visit www.essilor.com.
The Essilor share trades on the NYSE Euronext Paris market and is included in
the EuroStoxx 50 and CAC 40 indices.
Codes and symbols: ISIN: FR0000121667; Reuters: ESSI.PA; Bloomberg: EI:FP.
Investor Relations and Financial Communication
Véronique Gillet – Sébastien Leroy – Ariel Bauer
Phone: +33 (0)1 49 77 42 16
Phone: +33 (0)1 49 77 45 02
Press spacebar to pause and continue. Press esc to stop.